Oncological drug crisis in Romania: Patients report lack of treatments, authorities deny the problem
Cancer patients in Romania are currently facing major difficulties in finding the cytostatic drugs necessary for their vital treatments. Numerous individuals have reported that stocks are depleted in many pharmacies and hospitals across the country, which puts the continuity of oncological therapies at risk.
Representatives of patient associations claim that this drug crisis has become a constant problem, forcing patients to seek desperate solutions to procure their treatment. They warn that interrupting the administration of cytostatics can have serious consequences on the health status and recovery chances of those affected.
In response, the head of the National Health Insurance House (CNAS) stated that the situation is under control and that there is no real drug crisis on the Romanian market. The official specified that supply is proceeding according to schedule and that all necessary medicines are, in theory, available to insured patients.
This discrepancy between official statements and the direct experience of patients has generated numerous discussions in the public sphere. While the authorities claim that the system is functioning correctly, the reality in medical units suggests that the distribution of drugs to patients is encountering significant logistical or administrative bottlenecks.
In the coming period, the Ministry of Health is expected to verify warehouse stocks and clarify the reasons why patients cannot access the necessary treatments. Until a concrete solution is found, patients continue to depend on the limited availability of medicines in pharmacies.